Search Clinical Trials
Parent Therapeutic Areas: Oncology | Nephrology/Urology

Prostate Cancer

Alaska

Anchorage : Alaska Clinical Research Center

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Arizona

Sierra Vista : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Tucson : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Arkansas

Little Rock : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

California

Corona : Compassionate Cancer Care Medical Group, Inc.

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Duarte : City of Hope

A Phase Ib of Mushroom Powder in Biochemically Recurrent Prostate Cancer

Duarte : City of Hope

Androgen Deprivation and Localized Radiotherapy to Metastases in Patients with Oligometastatic Hormone - Sensitive Prostate Cancer

Duarte : City of Hope

CALGB 90203: A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer

Duarte : City of Hope

Determination of the Reliability of Expresssed Prostatic Secretion and Post Massage Urine Biomarkers in the Detection of Prostate Cancer in Men Undergoing Biopsy for Prostate Cancer

Duarte : City of Hope

Erectile Dysfunction Recovery in Men age

Duarte : City of Hope

Long Term Follow Up after Prostate Cancer

Duarte : City of Hope

Pre-Surgical EPS Biomarkers as Predictors of Recurrence

Duarte : City of Hope

Prostate Cancer Database

Duarte : City of Hope

RTOG 0534: A Phase III Trial of Short Term Androgen Deprivation with Pelvis Lymph Node or Prostate Bed Only Radiotherapy (SPORT)in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy

Duarte : City of Hope

SWOG S0421: Phase III Study of Docetaxel and Atrasentan versus Docetaxel and Placebo for Patients with Advanced Hormone Refractory Prostate Cancer

Fountain Valley : Compassionate Cancer Care Medical Group Inc

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Los Angeles : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Los Angeles : Cedars Sinai Medical Center

Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer

Rancho Mirage : Desert Hematology Oncology Medical Group

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Riverside : Compassionate Cancer Care Medical Group

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

San Diego : Sharp Clinical Oncology Research

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Connecticut

West Haven : Va Connecticut Healthcare System

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Florida

Aventura : South Florida Medical Research

Phase II, Clinical Trial For Patients with Prostate Cancer or Breast Cancer with Metastatic Disease

Aventura : South Florida Medical Research

Phase III, Open Label, One Year Trial Comparing the efficacy and safety of a study drug 3 month dosing regimen with study drug in patients with Prostate Cancer requiring Androgen Deprivation Therapy

Aventura : South Florida Medical Research, Inc.

Phase IV, Hormone Refractory Prostate Cancer Study

Aventura : South Florida Medical Research

Prostate Cancer/Breast Cancer study to evaluate the safety and effects on bone resorption of a study medication compared to another approved drug in patients with Metastatic Disease.

Naples : Specialists in Urology

A multicenter clinical study of the Sonablate 500 for the treatment of locally recurrent prostate cancer with HIFU

Naples : Specialists in Urology

Are you looking for a treatment for newly diagnosed Prostate Cancer?

Tallahassee : Southeastern Research Group, Inc.

A Phase III Study of Study Drug on Prolonging Bone Metastasis-Free Survival in Men with Hormone- Refractory Prostate Cancer

Georgia

Lawrenceville : Suburban Hematology/Oncology Associates

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Savannah : Memorial Health University Medical Center

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Savannah : Memorial Health University Medical Center

Soy Protein/Isoflavones and Venlafaxine in Treating Hot Flashes in Patients Receiving Hormone Therapy for Prostate Cancer CCCWFU 97405

Idaho

Coeur D'Alene : Kootenai Cancer Center

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Illinois

Chicago : University Of Chicago

Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer

Chicago : University Of Chicago

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Elgin : Sherman Health Systems

S0421, "Phase III Study of Docetaxel and Atrasentan versus Docetaxel and Placebo For Patients with Advanced Hormone Refractory Prostate Cancer"

Zion : Midwestern Regional Medical Center

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Indiana

Fort Wayne : Fort Wayne Medical Oncology And Hematology Inc

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Jeffersonville : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Jeffersonville : Metropolitan Urology, PSC.

Have you been diagnosed with prostate cancer? Has the cancer spread to the bone? Is your PSA rising? If so you may qualify for a clinical research trial for the treatment of bone metastases in men with hormone-refractory prostate cancer.

Kansas

Wichita : Cancer Center Of Kansas

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Louisiana

New Orleans : Tulane University

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Maine

Scarborough : Maine Center For Cancer Medicine

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Maryland

Baltimore : The Bunting Blaustein Cancer Research Building

Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer

Massachusetts

Boston : Tufts Medical Center

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Mississippi

Jackson : Jackson Oncology Associates, Pllc

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Tupelo : N Miss Hem&Onc Assoc, Ltd

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Missouri

St. Louis : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

New Jersey

Cherry Hill : The Center For Cancer And Hematologic Disease

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Lawrenceville : AdvanceMed Research

Do you have Prostate Cancer?

Lawrenceville : AdvanceMed Research

Prostate Cancer that requires Hormone therapy.

Morristown : Atlantic Health System

A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)

Voorhees : Delaware Valley Urology, LLC

Have you been diagnosed with Prostate Cancer, Chronic Prostatitis, or Benign Prostatic Hyperplasia (BPH)?

New Mexico

NE Albuquerque : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

New York

Albany : New York Oncology Hematology, Pc

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Albany : New York Oncology Hematology, Pc

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Bronx : Biomedical Research Alliance of New York

Clinical trial to test a study drug in heart failure and renal (kidney) insufficiency

Bronx : Biomedical Research Alliance of New York

Prostate Cancer - Adult Men

Bronx : Biomedical Research Alliance of New York

Prostate Cancer - Adults

Buffalo : Roswell Park Cancer Institute

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

East Setauket : North Shore Hematology/Oncology Associates, P.C.

Phase 2, Multicenter, Randomized Study of IMC-A12 or IMC-1121B Plus Mitoxantrone and Prednisone in Metastatic Androgen-Independent Prostate Cancer (AIPC) Following Disease Progression on Docetaxel-Based Chemotherapy

New Hyde Park : Biomedical Research Alliance of New York

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer (CRPC)

New York : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

New York : Mount Sinai Medical Center

A Phase II Study of Weekly Taxol and Estramustine for Treatment of Prostate Cancer Micrometastases after Radical Prostatectomy or Salvage Radiation Therapy

New York : Mount Sinai Medical Center

Diagnosis of Prostate Cancer Using Multigene Expression Signatures

New York : Mount Sinai Medical Center

Docetaxel and Estramustine versus Mitoxantrone and Prednisone for Advanced Hormone Refractory Prostate Cancer, Phase III
Sponsor: CALGB

New York : Mount Sinai Medical Center

Efficacy of combined prophylactic and on demand Sildenafil usage in potent men undergoing brachytherapy and hormonal therapy for localized prostate cancer.

New York : Mount Sinai Medical Center

Neoadjuvant/Adjuvant Docetaxel and Estramustine in Combination with Brachytherapy and Three-Dimensional Conformal Radiotherapy

New York : Mount Sinai Medical Center

Phase I Trial of Adenovirus- Mediated IL-12 Gene Transduction in Patients with Radiorecurrent Prostate Cancer

New York : Memorial Sloan-Kettering Cancer Center-Sidney Kimmel Center

Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer

New York : Memorial Sloan-Kettering Cancer Center

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Nyack : Hematology-Oncology Associates Of Rockland

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Staten Island : Staten Island Urological Research, P.C.

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Double-Blind , Dose-Ranging Clinical Trial To Study The Efficacy And Safety of 5, 15 or 25mg/day CyPat (Cyproterone Acetate) for the Treatment of Hot Flashes Following Surgical or Medical Castration of Prostate Cancer Patients

Staten Island : Staten Island Urological Research, P.C.

A Phase 3, Randomized, Open-label Study Evaluating DN-101 in Combination with Docetaxel in Androgen Independent Prostate Cancer (AIPC) (ASCENT2)

Staten Island : Staten Island Urological Research, P.C.

A Randomized, Double Blind, Placebo Controlled Trial of Immunotherapy with Autologous Antigen-Loaded Dendritic Cells For Asymptomatic Metastatic Hormone Refractory Prostate Cancer.

Staten Island : Staten Island Urological Research, P.C.

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab on Prolonging Bone Metastasis-Free Survival in Men with Hormone Refractory Prostate Cancer

Staten Island : Staten Island Urological Research, PC

Concerned about bone loss associated with your prostate cancer therapy?

Staten Island : Staten Island Urological Research, P.C.

Prostate Cancer Bone Loss Study.

Staten Island : Staten Island Urological Research, P.C.

Prostate Cancer Prevention Clinical Trial

Staten Island : Staten Island Urological Research, P.C.

Prostate cancer trial

North Carolina

Chapel Hill : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Charlotte : USHIFU

A multicenter clinical study of the Sonablate® 500 (SB-500) for the treatment of locally recurrent prostate cancer with HIFU

Durham : Duke University

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Winston-Salem : Piedmont Hematology Oncology Associates

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

North Dakota

Bismarck : St. Alexius Medical Center

A research study for prostate cancer patients

Ohio

Columbus : Mid Ohio Oncology/Hematology, Inc,Dba

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Oregon

Portland : Providence Portland Med Ctr

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Pennsylvania

Philadelphia : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Philadelphia : Fox Chase Cancer Center

Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer

Pittsburgh : Va Medical Center Pittsburgh Healthcare System

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Pittsburgh : Upmc Cancer Pavilion

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Upland : Associates In Hematology & Oncology, P.C.

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

South Carolina

Greenville : Cancer Centers Of The Carolinas

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Mt. Pleasant : Lowcountry Hematology & Oncology Pa

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Texas

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplaston A10 And AS2-1 Private Capsules In Patients With Incurable, Stage C Or D Adenocarcinoma Of The Prostate

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplaston A10 And AS2-1 Private Capsules In Combination With Total Androgen Blockade In Patients With Adenocarcinoma Of The Prostate

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Adenocarcinoma Of The Prostate

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Adenocarcinoma Of The Prostate

Houston : The University Of Texas Md Anderson Cancer Center

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Washington

Seattle : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Seattle : Research Site:

A Study of Epothilone D in Patients With Metastatic Prostate Cancer

Seattle : Seattle Cancer Care Alliance

Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer

Seattle : The University Of Texas Md Anderson Cancer Center University Of Washington

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Wisconsin

Madison : University Of Wisconsin Paul P Carbone Comprehensive Ca Ctr

Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer

Madison : Dean Hematology And Oncology Clinic University Of Washington

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer

Belgium

Bruxelles : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Leuven : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Brazil

Horizonte : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Rio Grande : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Sao Paulo : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Sao Paulo : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Sao Paulo : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Colombia

Antioquia : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Bogota : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Bogota : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Cundinamarca : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Cundinamarca : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Denmark

Aalborg : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Arhus : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Odense : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Finland

Oulu : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Tampere : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

France

Lyon : Research Site:

A Study of Pertuzumab in Patients With Prostate Cancer.

Montpellier : Research Site:

A Study of Pertuzumab in Patients With Prostate Cancer.

Montpellier : Centre Val D'Aurelle-Parc Lamarque

Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer

Paris : Hopital Europeen Georges Pompidou

Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer

Villejuif Cedex : Institut Gustave Roussy

Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer

Germany

Berlin : Research Site:

A Study of Pertuzumab in Patients With Prostate Cancer.

Holland

Rotterdam, Zuid : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Rotterdam, Zuid : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Ireland

Belfast : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Italy

Milano : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Parma : Research Site:

A Study of Pertuzumab in Patients With Prostate Cancer.

Roma : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Roma : Research Site:

A Study of Pertuzumab in Patients With Prostate Cancer.

Rome : Azienda Ospedaliera S. Camillo Forlanini

Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer

Netherlands

Rotterdam : Research Site:

A Study of Pertuzumab in Patients With Prostate Cancer.

Peru

Lima : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Lima : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Poland

Dolnoslaskie : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Lubelskie : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Lubelskie : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Podlaskie : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Swietokrzyskie : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Scotland

Glasgow : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Spain

Barcelona : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Barcelona : Research Site:

A Study of Pertuzumab in Patients With Prostate Cancer.

Madrid : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Navarra : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Sevilla : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Torino : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Valencia : Research Site:

A Study of Pertuzumab in Patients With Prostate Cancer.

Sweden

Goteborg : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Lund : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Uppsala : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

United Kingdom

Bristol : Research Site:

A Study of Pertuzumab in Patients With Prostate Cancer.

Cardiff : Research Site:

A Study of Pertuzumab in Patients With Prostate Cancer.

London : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

London   : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Surrey : Research Site

A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer

Sutton : Research Site:

A Study of Pertuzumab in Patients With Prostate Cancer.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.